beneficiari increas ventil demand
us pull forward demand ahead june
invest thesi ew us share price year date cdi
price vs close level move
ow ew see trade mse ep vs
averag consensu thomson price target
premium valuat could remain long street continu believ upsid
relat ventil sale off-set potenti eros base
sleep apnea osa busi reinstal bull case
weight reflect street on-going focu vent proven otherwis
result juli
industri discuss highlight follow strong demand
ventil though smaller portion busi ii us may seen
pull forward osa patient demand march ahead social distanc
measur could suggest robust revenu market iii risk
june/sept quarter suffer social distanc upsid vent
enough off-set iv increas lobbi delay detail see
 pervas across broader time period row
us henc number could weaker vi long-term prospect
could impact yet formal institut
estim impact estim within
note ran scenario model increas vent sale drag osa
demonstr possibl mid-singl digit gross profit gp upsid
march low-doubl digit downsid gp june septemb qs
ms vs expect revenu ii
gp margin iii ep
expect revenu ii gp
margin iii ep
up/downsid price target
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
exhibit statist resm cdi
price target convert cdi
morgan stanley research cdi disclaim end report
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
analyst employ non-u affili regist
finra may associ person member may
subject finra restrict commun subject
compani public appear trade secur held
see two main impact busi pandem
slowdown new patient start cpap therapi would impact devic sale
lesser extent mask resuppli
upsid ventil
ventil repres small portion overal busi assum ventil
sale repres devic sale whole group
significantli lift product issu press releas march
ceo mick farrel said look doubl tripl output
ventil scale ventil mask product tenfold
april us depart human servic hh announc five
new contract ventil product hill-rom
 vyair award contract ventil produc
juli may june price million
april australian minist announc deliveri ventil
contract go toward
downsid cpap devic resuppli
industri dilig suggest slow new starter channel check
us base cpap supplier learnt demand product strong
month march howev gener expect slow april
onward mainli due slower doctor referr mani practic shut result
lookdown
impact mask resuppli sale expect devic replac
resuppli exist cpap patient continu given patient abl servic
remot receiv item mail estim devic sale
new patient major mask sale resuppli patient alreadi
therapi mean mask sale insul slow new patient
start devic
exhibit cpap devic sale pre post
exhibit gp devic pre post
exhibit estim devic sale new patient
major mask sale resuppli patient alreadi
exhibit mask resuppli sale pre post
mask
combin impact lower cpap mask sale partli off-set higher
revenu gp
revenu gp
revenu gp
exhibit impact revenu
exhibit impact gp
exhibit scenario analysi higher ventil sale off-set lower devic mask sale
mse
exhibit mse us devic revenu
exhibit mse us mask revenu actual fx
exhibit mse row devic revenu actual fx
exhibit mse row mask revenu actual fx
exhibit continu trade near record high pe multipl
resm inc forward price earn
exhibit consenu forward earn revis
exhibit mse
exhibit mse
price target set equal base case
weight
move blend price target
use bull case skew
think market like pay
premium given expect upsid
ventil sale
ad upsid scenario
ventil sale increas sustain
period time
wide dispers outcom exist
price target set use blend methodolog appli bull-base-bear scenario
weight use bull case skew think market like pay
premium near term upsid ventil sale base case valu use dcf
methodolog wacc lt growth assumpt
rate ew
see long durat growth support
larg instal base growth ii
resuppli sale iii on-going oper
good ep certainti busi
momentum driven
share price excess price target
feel ew rate
view descript risk reward theme
us eu devic revenu growth
volum growth pa iv asp
pressur gm next year
higher longer ventil sale due
appli dcf valuat
forecast includ step us
growth rate associ new product
launch decay pa long term
reduct us mask price ii poc
remain market share iii
devic price iv resuppli volum
growth line devic growth
continu penetr obstruct sleep
high growth high-margin mask/dispos
china india
view explan region hierarchi
research highest favor quintil
higher market share cpap
faster-than-expect benet recent
round competit bid
higher ventil sale due
advers impact us competit bid
loss cpap market share
eur usd continu deterior
lower cpap devic resuppli sale due
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
wide dispers outcom exist
price target cdi deriv price target use ratio cdi
investor awar calcul take account issu risk
associ invest adr includ limit liquid vote right
dividend volatil currenc exchang rate uctuat
rate ew
see long durat growth support
larg instal base growth ii
resuppli sale iii on-going oper
good ep certainti busi
momentum driven
share price excess price target
feel ew rate
view descript risk reward theme
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
us devic growth higher current
forecast addit small move mask
turn see upsid poc reach
share higher longer ventil sale
appli dcf valuat
forecast includ step us
growth rate associ new product
launch decay pa long term
bear case assum reduct us
mask price reduct us unit growth
remain intern level pa
poc remain market share
continu penetr obstruct sleep
high growth high-margin mask/dispos
china india
view explan region hierarchi
higher market share cpap
faster-than-expect benet recent
round competit bid
higher ventil sale due
advers impact us competit bid
loss cpap market share
eur usd continu deterior affect
lower cpap devic resuppli sale due
profit loss
growth pcp
growth pcp
abn extra tax
return asset
return equiti
growth pcp
growth pcp
growth pcp
growth pcp
growth pcp
growth pcp
growth pcp
fy sale
 fy ebit
dep amort
gross cash op ns
inc dec wk cap
chg loan
net chg cash
compani data research research estim note provid research coverag
list cdi associ underli ordinari share compani courtesi may includ cdi price target cdi
share price aud dollar research report unless otherwis state cdi price target convers calcul use appropri
currenc exchang rate ordinari share versu cdi ratio investor awar calcul take account issu
risk associ invest cdi includ limit liquid vote right dividend volatil currenc exchang rate fluctuat
